Wolff SM. 1973. Biological effects of bacterial endotoxins in man. Journal of Infectious Diseases 128(Suppl.):S259-S264.
Woodbury LA. 1978. Incidence and prevalence of seizure disorders including the epilepsies in the United States of America: a review and analysis of the literature. In: Plan for Nationwide Action on Epilepsy, Vol. 4: The Commission for the Control of Epilepsy and its Consequences. DHEW Publication No. (NIH) 78-279. Washington, D.C.: U.S. Department of Health, Educaion, and Welfare.
Yajima M, Hosoda K, Kanbayashi Y, Nakamura T, Nogimori K, Muzushima Y, Nakase Y, Ui M. 1978. Islet-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Journal of Biochemistry 83:295-303.
Yamauchi T. 1986. The controversy in clinical medicine regarding the risks and benefits of pertussis immunization. Neurotoxicology 7:47-51.
Yamasaki S. 1983. Side effects after improved DPT vaccine. Annales Paediatrici Japonici 29:24.
Yannet H, Deamer WC, Barba PS. 1949. Convulsive disorders in children. Round Table Discussion, American Academy of Pediatrics. Pediatrics 4:677-680.
Yannet H. 1951. The treatment and prognosis of convulsive disorders in children. Bulletin of the New York Academy of Medicine 27:466-474.
Zahalsky AC. 1989a. Biological activities and properties of Bordetella pertussis toxins. May 1989. Unpublished.
Zahalsky AC. 1989b. Some biochemical mechanisms and consequences of the joint action(s) of pertussis toxin and endotoxin in humans. June 1989. Unpublished.
Zahalsky AC. 1989c. Neurotoxicity via permeability of cerebral capillaries. July 1989. Unpublished.
Zahalsky AC. 1989d. A contributing mechanism to cell injury following inoculation with whole cell DTP vaccine (adsorbed): ADP-ribosylation by pertussis toxin as potential inhibitor of essential energy yielding reactions. October 1989. Unpublished.
Zahalsky AC. 1990. Scientific basis for including tests of acute phase reaction products in clinical protocols designed to investigate the cause of adverse reactions following inoculation(s) in infants with DTP (ads.) vaccine. Institute of Medicine Public Meeting on Adverse Consequences of Pertussis and Rubella Vaccines, Washington, DC, January 10, 1990. Unpublished.
Zeffer KB, Sauer MV. 1988. Orchitis after a rubella vaccination: a case report. Journal of Reproductive Medicine 33:80-81.
Zellweger H. 1959. Pertussis encephalopathy. Archives of Pediatrics 76:381-386.
Zellweger H, Steinegger R. 1950. Zur Klinik und Pathogenese der Pertussisencephalopathie. Helvetica Paediatrica Acta 5:139.
Zhang JM, Cowell JL, Steven AC, Carter PH, McGrath PP, Manclark CR. 1985a. Purification and characterization of fimbriae from Bordetella pertussis. Infection and Immunity 48:422-427.
Zhang JM, Cowell JL, Steven AC, Manclark CR. 1985b. Purification of serotype 2 fimbrae of Bordetella pertussis and their identification as a mouse protective antigen. Developments in Biological Standardization 61:173-185.
Zuelzer WW, Mastrangelo R, Stulberg CS, Poulik MD, Page RH, Thompson RI.